|Bid||0.00 x 900|
|Ask||0.00 x 1800|
|Day's Range||13.53 - 14.23|
|52 Week Range||13.53 - 20.00|
|Beta (3Y Monthly)||2.05|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 5, 2018 - Nov 9, 2018|
|Forward Dividend & Yield||0.05 (0.36%)|
|1y Target Est||22.00|
NEW YORK, Oct. 12, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Invacare Corporation (NYSE:IVC) shareholders, and potential investors, need to understand how much cash the business makes from its core operational activities, as well as how much is invested back intoRead More...
The Board of Directors of Invacare Corporation announced that it declared a cash dividend of $.0125 per share on its common shares payable October 26, 2018 to shareholders of record on October 12, 2018.
Invacare Corporation (IVC) today announced its conference schedule for September 2018. On Wednesday, September 12, at 5:25 p.m. ET, Matthew E. Monaghan, chairman, president and chief executive officer will present at the Morgan Stanley 2018 Global Healthcare Conference at the Grand Hyatt in New York. The live webcast of the presentation will be available at https://cc.talkpoint.com/morg007/091218a_as/?entity=29_68B6B6D and it will be accessible for replay for 90 days following the conference.
Invacare Corporation (NYSE: IVC ), a manufacturer and distributor of medical equipment used in non-acute care settings, signaled in its second-quarter earnings report a turnaround is not progressing as ...
NEW YORK, Aug. 13, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of East ...
NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Invacare Corporation (NYSE: IVC ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 8:30:00 AM Eastern Time. ...
Invacare (IVC) delivered earnings and revenue surprises of -17.14% and -0.71%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
On a per-share basis, the Elyria, Ohio-based company said it had a loss of 50 cents. Losses, adjusted for one-time gains and costs, came to 41 cents per share. The wheelchair, crutches and motorized scooter ...
Invacare Corporation announces that it will release its financial results for the second quarter ended June 30, 2018, after the market closes on Tuesday, August 7, 2018.
Matthew E. Monaghan, chairman, president and chief executive officer and Kathy Leneghan, senior vice president and chief financial officer of Invacare Corporation , will participate in the 3rd Annual Needham MedTech 1x1 Conference in Boston on Tuesday, August 7, 2018.
Invacare Corporation (IVC) today announced the appointment of Diana S. Ferguson, to its Board of Directors, effective July 19, 2018. Ms. Ferguson currently serves as Chief Financial Officer for Cleveland Avenue, LLC, a privately-held venture capital firm which accelerates and strategically invests in innovative restaurant, food and beverage concepts and emerging brands. In addition, since August 2013, Ms. Ferguson has served as Principal of Scarlett Investments, LLC, a firm that invests in and advises middle market businesses.
Matthew E. Monaghan, chairman, president and chief executive officer of Invacare Corporation , will present at the 18th Annual “New Ideas” Summer Conference in New York, on Tuesday, July 10, 2018.
Invacare Corporation (IVC) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock
Invacare Corporation (IVC) today announced the appointment of Petra Danielsohn-Weil, PhD, to its Board of Directors, effective May 17, 2018. From 2014 until her retirement in August 2017, Ms. Danielsohn-Weil was the Regional President for Pfizer Essential Health - Europe, a leader in non-viral anti-infectives, biosimilars and sterile injectable medicines and a unit of Pfizer Inc. (PFE), a research-based, global biopharmaceutical company.
The Board of Directors of Invacare Corporation announced that it declared a cash dividend of $.0125 per share on its common shares and $.011364 per share on its Class B common shares payable July 20, 2018 to shareholders of record on July 6, 2018.